Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$612.81NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/29/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$609.05 (14)
Ask (Size)$614.00 (1)
Day Low / HighN/A - N/A
Volume6.7 M

Regeneron Pharmaceuticals Says Trial Shows Efficacy in Genetic Cholesterol Disorder Treatment

11:47AM ET 8/14/2019 MT Newswires
Regeneron Pharmaceuticals (REGN) said it achieved positive phase 3 trial results for evinacumab, a monoclonal antibody that specifically binds to angiopoietin-like protein 3 (ANGPTL3), in patients with homozygous familial hypercholesterolemia ((HoFH), a genetic disorder wherein patients have a high level of bad cholesterol or LDL cholesterol.

Price: 299.48, Change: -5.38, Percent Change: -1.76